Q Therapeutics is a privately-held, actively reporting U.S. biotechnology company founded on the ground-breaking work of Dr. Mahendra Rao during his tenure at the University of Utah and the National Institutes of Health. Dr. Rao is recognized as one of the world’s top stem cell researchers, particularly in the area of neural stem cells and, until recently, served as the Director of the Intramural Center for Regenerative Medicine at the National Institutes of Health (NIH).
After a decade of research, development and validation, we are now leading a novel stem cell therapeutic approach to CNS disease through replacing myelin and restoring neuronal function with a human glial progenitor cell technology platform.
Our first product, Q-Cells®, will undergo first-in-human trials for ALS in 2016. Our therapeutic strategy is intended to restore the normal activity of neurons by providing the support functions present in healthy central nervous system tissue. Q-Cells® are adult stem cells, restricted in their ability to differentiate only into glia, the unsung heroes of the brain. While little was known about their function until recently, we now know that glial cells play an essential role in creating a healthy cellular environment for neurons and make up about 50% of the brain's mass. Our unique Q-Cells® approach is comprehensively protected by more than 20 issued patents with more pending.
Following our initial trial in ALS, we are hopeful that the restorative mechanism of Q-Cells® will be applicable to a wide range of central nervous system diseases, including demyelinating conditions such as multiple sclerosis, transverse myelitis, cerebral palsy and stroke; as well as other neurodegenerative diseases and injuries such as Huntington’s disease, spinal cord injury, traumatic brain injury, Parkinson’s disease and Alzheimer’s disease.
- Transverse Myelitis
- Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig’s Disease)
- Multiple Sclerosis
- Spinal Cord Injury
- Huntington’s Disease
- Parkinson’s Disease
- Alzheimer’s Disease
- Traumatic Brain Injury